Utility Values Associated with Atypical Hemolytic Uremic Syndrome-Related Attributes: A Discrete Choice Experiment in Five Countries

BACKGROUND: Atypical hemolytic uremic syndrome is a rare disease caused by complement dysregulation that can lead to progressive kidney damage or death if untreated. Owing to its rarity, the impact of atypical hemolytic uremic syndrome and available therapies (eculizumab and ravulizumab) on patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Kate, Aggio, Daniel, Chen, Peter, Anokhina, Katerina, Lloyd, Andrew J., Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298227/
https://www.ncbi.nlm.nih.gov/pubmed/34195967
http://dx.doi.org/10.1007/s40273-021-01059-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298227/
https://www.ncbi.nlm.nih.gov/pubmed/34195967
http://dx.doi.org/10.1007/s40273-021-01059-w

Ejemplares similares